The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6605535.pdf
Reference41 articles.
1. Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S (2004) A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost 2: 1266–1271
2. Baker M, Wayland H (1974) On-line volume flow rate and velocity profile measurements for blood in microvessels. Microvasc Res 7: 131–143
3. Barner M, Eldor A, Wasserman L, Matzner Y, Cohen IR, Fuks Z, Vlodavsky I (1987) Inhibition of heparanase-mediated degradation of extracellular-matrix heparan-sulfate by non-anticoagulant heparin species. Blood 70: 551–557
4. Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, Carmeliet P, Mueller BM, Friedlander M, Ruf W (2004) Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nature Med 10: 502–509
5. Carrier M, Agnes YY (2009) Prophylactic and therapeutic anticoagulation for thrombosis-major issues in oncology. Nat Clin Pract Oncol 6: 74–84
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The molecular evidence behind the adjunct use of anticoagulants and chemotherapy in pancreatic cancer treatment: A new role for anticoagulants?;Human Gene;2024-09
2. A celastrol-based nanodrug with reduced hepatotoxicity for primary and metastatic cancer treatment;eBioMedicine;2023-08
3. Heparanase and the hallmarks of cancer;Journal of Translational Medicine;2020-11-30
4. A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models;Thrombosis Research;2020-11
5. Natural Products and Nanopharmaceuticals;Nanopharmaceuticals: Principles and Applications Vol. 2;2020-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3